Relative Bioavailability of Dabigatran and Digoxin in Healthy Male and Female Volunteers

Phase 1 Completed 24 enrolled Boehringer Ingelheim

RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the bioavailability of dabigatran with and without concomitant administration of digoxin and the bioavailability of digoxin with and without concomitant administration of dabigatran etexilate

Timeline

Start: 2006-06
Primary completion: 2006-08
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dabigatran etexilate	Unknown	150 mg	Oral
Subject	Digoxin	Other / unclassified	0.25 mg	Oral

Indications

No indication recorded.